YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...
The "Human Factors and Usability Engineering in the Development of Drug Delivery Products Training Course (Feb 11th - Feb 12th, 2026)" training has been added to ResearchAndMarkets.com's offering.
Abstract: The challenge of accurately locating multitarget in complex environments has become increasingly critical as radar technology evolves. Traditional phased array radars utilize 1-D measurement ...
Objectives In patients with chronic obstructive pulmonary disease (COPD), severe exacerbations (ECOPDs) impose significant morbidity and mortality. Current guidelines emphasise using ECOPD history to ...
Video of brutal Seattle attack on elderly woman sparks anger Email from ‘A’ at British royal family’s residence asked Ghislaine Maxwell for ‘inappropriate friends’ Dread, tears as Tyson plans to lay ...
Abstract: Accurate prediction of drug-target interactions (DTIs) is crucial for accelerating drug discovery and reducing experimental costs. However, challenges such as sparse interactions and ...
Phase III is intended to generate meaningful biological data on potential drug compounds prioritized by YuvaBio’s classifier, which applies proprietary machine-learning methods to identify candidates ...
(CBS, KYMA) - Sen. Bill Cassidy (R-La.) spoke with Margaret Brennan on Face the Nation Sunday about healthcare proposals. According to Brennan, Sen. Cassidy's healthcare bill gives "Americans up to $1 ...
The FDA is raising the bar for approval of CAR T-cell therapies in oncology. Under plans outlined by the FDA’s biologics chief Vinay Prasad, M.D., the agency will require developers of many CAR-Ts to ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback